Metropolitan Life Insurance Company (MetLife)’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,505
Closed -$105K 2885
2021
Q3
$105K Sell
4,505
-50
-1% -$1.05K ﹤0.01% 2492
2021
Q2
$98.6K Buy
4,555
+349
+8% +$7.94K ﹤0.01% 2594
2021
Q1
$132K Buy
+4,206
New +$132K ﹤0.01% 2291
2014
Q4
Sell
-7,919
Closed -$165K 2681
2014
Q3
$165K Hold
7,919
﹤0.01% 2511
2014
Q2
$314K Buy
7,919
+3,032
+62% +$94.3K ﹤0.01% 2163
2014
Q1
$175K Hold
4,887
﹤0.01% 2553
2013
Q4
$295K Hold
4,887
﹤0.01% 2196
2013
Q3
$208K Buy
4,887
+70
+1% +$4.39K ﹤0.01% 2399
2013
Q2
$297K Buy
+4,817
New +$203K ﹤0.01% 2054

Metropolitan Life Insurance Company (MetLife)'s XONE Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of The ExOne Company (XONE) in Q4 2021, closing a stake of 4,505 shares — an estimated $105K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in XONE in Q2 2013 and held it in 9 quarters. The position peaked at $314K in Q2 2014. 0 funds tracked by Wall St. Rank hold XONE as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining The ExOne Company position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,505 The ExOne Company shares in Q4 2021, an estimated $105K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in The ExOne Company in Q2 2013 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s The ExOne Company position peaked at $314K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held The ExOne Company as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.